Table 4.
Clinical characteristics and microbiological details of VRE infected patients admitted to the ICU
| Age (years) | Gender | Specimen | Clinical data | Enterococcus spp. | Resistance phenotype | VAN (μg/ml) | TP (μg/ml) | LZD | Treatment |
|---|---|---|---|---|---|---|---|---|---|
| 3 | Female | Blood | Short bowel syndrome-pleural effusion | E. faecium | VAN A | >256 | >256.00 | S | NA |
| 59 | Male | Blood | IHD-CAP-fever-DM-HF | E. faecium | NA | >16 | 1.00 | S | TAZ-CRO-AZT |
| 34 | Male | Blood | AIDS-PCP-Kaposi sarcoma, septic shock | E. faecium | VAN A | >256 | 16.00 | S | NA |
| 35 | Male | Blood | CML, fever | E. faecium | VAN B | 32 | 0.25 | S | COL, VAN |
| 65 | Male | Urine | P-CABG | E. faecium | VAN B | 16 | 1.00 | R | VAN + MER |
| 34 | Female | Blood | AML-central line | E. faecium | VAN A | >256 | >256.00 | S | AK-CAZ-VAN |
| 67 | Female | Wound swab | Postlaparotomy | E. faecium | NA | 16 | 1.00 | S | MER-LZD |
| 62 | Female | Blood | Postcardiac surgery, tracheostomy | E. faecium | VAN A | >256 | >256.00 | S | NA |
| 82 | Male | Blood | Postlaparotomy | E. faecium | VAN B | >32 | >16.00 | S | NA |
| 72 | Female | Blood | P-CABG | E. faecium | >16/24 | 0.75 | S | MER-VAN | |
| 44 | Male | Wound swab | DM, HTN, sacral infected wound | E. faecium | VAN B | >16 | 0.25 | S | MER-VAN |
| 75 | Female | Blood | Brachial artery thrombosis | E. faecium | VAN B | >16 | >0.25 | S | VAN |
| 1 | Female | Blood | Brain tumor, neutropenia, fever, chemotherapy | E. faecium | NA | >32 | >32.00 | S | NA |
| 2* | Female | Blood | Short bowel syndrome-fever | E. gallinarum | NA | 6 | 1.00 | S | VAN + MTZ |
| 77 | Male | Wound swab | Septic arthritis, fever | E. gallinarum | NA | 16 | 1.00 | S | NA |
| 33 | Female | Wound swab | Polymyositis | E. gallinarum | NA | 4 | 0.25 | S | NA |
*2 months old. P-CABG: Postcoronary artery bypass grafting; DM: Diabetes mellitus; HTN: Hypertension; IHD: Ischemic heart disease; HF: Heart failure; CAP: Community acquired pneumonia; AML: Acute myeloid leukemia; CML: Chronic myeloid leukemia, AIDS: Acquired immune deficiency syndrome; PCP: Pneumocystis carinii pneumonia; NA: Not available; TAZ: Tazocin (piperacillin and tazobactam); CRO: Ceftriaxone; AZT: Aztreonam; VAN: Vancomycin; MTZ: Metronidazole; MER: Meropenem; LZD: Linezolid; AK: Amikacin; CAZ: Ceftazidime; COL: Colistin; R: Resistant; S: Sensitive; VRE: Vancomycin-resistant enterococci; E. faecium: Enterococcus faecium; E. gallinarum: Enterococcus gallinarum; TP: Teicoplanin; ICU: Intensive Care Unit.